DV
Dividend Vision

SLDB — Solid Biosciences LLC

Solid Biosciences LLC (SLDB)

Total return is -97.3% over the past 8.5 years, 305.9 points behind SPY at 208.6%. Its deepest 1-year drawdown was 41.2%.

This is a single-stock equity holding in Solid Biosciences, a biotechnology company focused on gene therapy development. The fund does not currently offer dividend distributions, making it unsuitable for income-focused investors seeking regular payouts. It appeals primarily to growth-oriented investors interested in exposure to the biotech and gene therapy sector, though the lack of available expense ratio and distribution data limits standard dividend ETF comparison metrics.

SLDB key facts

Asset type
Stock
Asset class
Equity
Inception date
01/26/2018
Last close
$9.20
Market cap
$831,899,200
Average volume
759399.0
Beta
2.364
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.86